LITS
Lite Strategy, Inc.
Key Financials
Operating Income
$-17455000
↓ 220.0%
Revenue
$0
↓ 100.0%
Net Income
$-15945000
↓ 189.7%
Total Liabilities
$1.4M
↓ 83.8%
Total Assets
$18.3M
↓ 55.8%
EPS (Diluted)
$-2.39
↓ 189.5%
Cash & Equivalents
$18.0M
↑ 386.1%
Shareholders' Equity
$16.9M
↓ 48.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/13/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
| 8-K | 2/17/2026 | View on SEC |
| 10-Q | 2/17/2026 | View on SEC |
| 4 | 2/12/2026 | View on SEC |
| 8-K | 2/12/2026 | View on SEC |
| DEFA14A | 1/27/2026 | View on SEC |
| ARS | 12/30/2025 | View on SEC |
| DEFA14A | 12/30/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LITS |
| Company Name | Lite Strategy, Inc. |
| CIK | 1262104 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 858-369-7100 |